Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT M&A.
Danaher To Acquire Masimo Corporation
Danaher Corporation, a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation, a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, Danaher will acquire all of the outstanding shares of Masimo common stock for $180 per share in cash, or a total enterprise value of approximately $9.9 billion including assumed indebtedness and net of acquired cash. This represents a transaction multiple of approximately 18x estimated 2027 EBITDA, or 15x 2027 estimated EBITDA, including the full benefit of expected annual synergies.
Rainer M. Blair, President and Chief Executive Officer at Danaher, said, “We are excited to welcome the Masimo team to Danaher. We’ve followed this innovative company for many years and see it as an exceptional strategic fit for Danaher. Masimo is a leader in pulse oximetry and other patient monitoring solutions, which, combined with its trusted brand and differentiated technology, will greatly strengthen our diagnostics franchise. With the Danaher Business System and our global scale, we see opportunities to expand Masimo’s reach and continue improving outcomes for patients, particularly those in acute care settings.”
Julie Sawyer Montgomery, Executive Vice President for Diagnostics at Danaher, said, “Masimo’s advanced sensor technology and AI-enabled monitoring bring powerful new capabilities to our diagnostics portfolio. Integrating these strengths into Danaher will create meaningful opportunities to innovate for clinicians and improve decision-making in critical settings.”
Upon completion of the transaction, Masimo will be a standalone operating company within Danaher’s Diagnostics segment, along with Radiometer, Leica Biosystems, Cepheid, and Beckman Coulter Diagnostics. Masimo is expected to be accretive to adjusted diluted net earnings per common share by $0.15 to $0.20 in the first full year and approximately $0.70 in the fifth full year following completion of the acquisition. Masimo is expected to deliver high-single-digit core revenue growth over the long-term, accelerating Danaher’s Diagnostics segment core revenue growth profile.
Under Danaher’s ownership, Masimo is expected to generate EBITDA of more than $530 million in 2027. Additionally, Danaher expects to realize more than $125 million of annual cost synergies and more than $50 million of annual revenue synergies by the fifth full year…
Full release here, originally announced February 17th, 2026.
Exa Capital Acquires StaffReady
Exa Capital, a strategic long-term operator that buys and holds enterprise software companies forever, is proud to announce the acquisition of StaffReady, a leading SaaS platform for clinical workforce management in healthcare.
Founded in 1995 and cloud-native since 2002, StaffReady delivers a mission-critical platform purpose-built for managing clinical workforces across multiple healthcare industries. The StaffReady platform supports hospital ancillary departments such as laboratories, pharmacies, PT, rehab, and support services, as well as standalone bioscience, pharmaceutical, and commercial lab test design corporations. The platform enables healthcare organizations to streamline compliance, staff scheduling, inspection preparation, and workforce readiness, ensuring the right people are in the right place at the right time.
The acquisition reinforces Exa Capital’s presence in healthcare technology and expands its portfolio into the space of clinical workforce, where efficiency, compliance, and patient safety intersect.
“StaffReady has built a platform that sits at the core of clinical workforce operations,” said Mike Knebel, Portfolio Manager at Exa Capital. “Their deep understanding of compliance, scheduling, and inspection readiness reflects years of thoughtful execution. We’re looking forward to working closely with the team to strengthen operations, support product innovation, and help scale the business responsibly over the long term.”
“Joining Exa Capital represents an exciting next chapter for StaffReady,” said John Janzen, Founder and CTO at StaffReady…
Full release here, originally announced February 16th, 2026.
No comments:
Post a Comment